LSDIF (Lucy Scientific Discovery) Accounts Payable & Accrued Expense: $1.99 Mil (As of Dec. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Lucy Scientific Discovery Accounts Payable & Accrued Expense?

Lucy Scientific Discovery LSDIF Accounts Payable & Accrued Expense is $1.99 Mil as of Dec. 2023.

Lucy Scientific Discovery's quarterly accounts payable & accrued expense declined from Jun. 2023 ($2.31 Mil) to Sep. 2023 ($1.83 Mil) but then increased from Sep. 2023 ($1.83 Mil) to Dec. 2023 ($1.99 Mil).

Lucy Scientific Discovery's annual accounts payable & accrued expense increased from Jun. 2021 ($3.53 Mil) to Jun. 2022 ($4.59 Mil) but then declined from Jun. 2022 ($4.59 Mil) to Jun. 2023 ($2.31 Mil).

Lucy Scientific Discovery Accounts Payable & Accrued Expense Historical Data

* Premium members only.

The historical data trend for Lucy Scientific Discovery's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lucy Scientific Discovery Accounts Payable & Accrued Expense Chart

Lucy Scientific Discovery Annual Data
Trend Jun21 Jun22 Jun23
Accounts Payable & Accrued Expense
3.53 4.59 2.31

Lucy Scientific Discovery Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 5.23 1.68 2.31 1.83 1.99

Lucy Scientific Discovery Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

What does a Accounts Payable & Accrued Expense of $1.99 Mil mean?
Lucy Scientific Discovery (LSDIF) has a Accounts Payable & Accrued Expense of $1.99 Mil as of Dec. 2023. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Lucy Scientific Discovery and its competitors.
Is Lucy Scientific Discovery's Accounts Payable & Accrued Expense too high?
Lucy Scientific Discovery's current Accounts Payable & Accrued Expense is $1.99 Mil.
How does Lucy Scientific Discovery's Accounts Payable & Accrued Expense compare to INQD and ZTS?
Lucy Scientific Discovery's Accounts Payable & Accrued Expense of $1.99 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable & Accrued Expense for a Drug Manufacturers company?
A good Accounts Payable & Accrued Expense depends on the Drug Manufacturers industry context. However, Accounts Payable & Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable & Accrued Expense mean?
A high Accounts Payable & Accrued Expense can signal that a stock is expensive relative to its fundamentals. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Lucy Scientific Discovery and its competitors. Lucy Scientific Discovery's current Accounts Payable & Accrued Expense is $1.99 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lucy Scientific Discovery stock overvalued right now?
Lucy Scientific Discovery (LSDIF) has a current Accounts Payable & Accrued Expense of $1.99 Mil. The current Accounts Payable & Accrued Expense is $1.99 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable & Accrued Expense calculated?
Accounts Payable & Accrued Expense is calculated from a company's financial statements. For Lucy Scientific Discovery (LSDIF), the current Accounts Payable & Accrued Expense is $1.99 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lucy Scientific Discovery Business Description

Address 301-1321 Blanshard Street, Victoria, BC, CAN, V8W 0B6
Lucy Scientific Discovery Inc is an early-stage psychotropics contract manufacturing company focused on becoming the contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry. Its drug products are designed to treat a range of mental health and cognitive conditions.